Stock Analysis

Iochpe-Maxion Full Year 2023 Earnings: Misses Expectations

BOVESPA:MYPK3
Source: Shutterstock

Iochpe-Maxion (BVMF:MYPK3) Full Year 2023 Results

Key Financial Results

  • Revenue: R$15.0b (down 12% from FY 2022).
  • Net income: R$30.7m (down 89% from FY 2022).
  • Profit margin: 0.2% (down from 1.6% in FY 2022). The decrease in margin was driven by lower revenue.
  • EPS: R$0.20 (down from R$1.84 in FY 2022).
earnings-and-revenue-growth
BOVESPA:MYPK3 Earnings and Revenue Growth March 8th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Iochpe-Maxion Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 3.8%. Earnings per share (EPS) also missed analyst estimates by 72%.

Looking ahead, revenue is forecast to grow 5.7% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Machinery industry in Brazil.

Performance of the Brazilian Machinery industry.

The company's shares are up 6.1% from a week ago.

Risk Analysis

Before we wrap up, we've discovered 3 warning signs for Iochpe-Maxion (1 is concerning!) that you should be aware of.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.